These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32812650)

  • 1. Postpartum metabolic syndrome and high-sensitivity C-reactive protein after gestational hypertension and pre-eclampsia.
    Osoti AO; Page ST; Richardson BA; Guthrie BL; Kinuthia J; Polyak SJ; Farquhar C
    Int J Gynaecol Obstet; 2020 Dec; 151(3):443-449. PubMed ID: 32812650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postpartum metabolic syndrome after gestational hypertension and preeclampsia, a prospective cohort study.
    Osoti AO; Page ST; Richardson BA; Guthrie BL; Kinuthia J; Polyak SJ; Farquhar C
    Pregnancy Hypertens; 2019 Oct; 18():35-41. PubMed ID: 31493627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Postpartum Levels of Cystatin and High-Sensitivity C-Reactive Protein and Duration of Lactation in Mothers with Previous Gestational Hypertension or Preeclampsia.
    Countouris ME; Demirci JR; Jeyabalan A; Catov JM; Schwarz EB
    Breastfeed Med; 2019; 14(6):408-415. PubMed ID: 30874448
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the prevalence of metabolic syndrome and levels of C-reactive protein after puerperium in women with hypertensive disorders during pregnancy.
    Vallejo Vaz AJ; Guisado ML; García-Junco PS; Andreu EP; Morillo SG; Ortiz JV
    Hypertens Res; 2010 Oct; 33(10):1012-7. PubMed ID: 20720554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein use in cardiovascular risk screening at 6 to 12 months postpartum following hypertensive disorders of pregnancy.
    Johnstone AM; Pudwell J; Ackerman-Banks CM; Lundsberg LS; Lipkind HS; Smith GN
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100776. PubMed ID: 36273813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension.
    Escouto DC; Green A; Kurlak L; Walker K; Loughna P; Chappell L; Broughton Pipkin F; Bramham K
    Pregnancy Hypertens; 2018 Jul; 13():218-224. PubMed ID: 30177055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and pre-eclampsia.
    Hooijschuur MCE; Ghossein-Doha C; Kroon AA; De Leeuw PW; Zandbergen AAM; Van Kuijk SMJ; Spaanderman MEA
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):64-71. PubMed ID: 30246464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizing the Window of Opportunity Within 1 Year Postpartum: Early Cardiovascular Screening.
    Ackerman-Banks CM; Grechukhina O; Spatz E; Lundsberg L; Chou J; Smith G; Greenberg VR; Reddy UM; Xu X; O'Bryan J; Smith S; Perley L; Lipkind HS
    J Am Heart Assoc; 2022 Apr; 11(8):e024443. PubMed ID: 35411781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Hypertensive Disorders in Pregnancy and Postpartum Plasma B Vitamin and Homocysteine Profiles in a High-Risk Multiethnic U.S., Population.
    Olapeju B; Ahmed S; Hong X; Wang G; Summers A; Cheng TL; Burd I; Wang X
    J Womens Health (Larchmt); 2020 Dec; 29(12):1520-1529. PubMed ID: 33252313
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women.
    Hauspurg A; Countouris ME; Jeyabalan A; Hubel CA; Roberts JM; Schwarz EB; Catov JM
    Pregnancy Hypertens; 2019 Jan; 15():1-6. PubMed ID: 30825904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study.
    Kumar N; Singh AK
    Curr Hypertens Rev; 2019; 15(2):154-160. PubMed ID: 30417791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum cardiovascular function in patients with hypertensive disorders of pregnancy: a longitudinal study.
    Giorgione V; Khalil A; O'Driscoll J; Thilaganathan B
    Am J Obstet Gynecol; 2023 Sep; 229(3):292.e1-292.e15. PubMed ID: 36935069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease-Related Pregnancy Complications Are Associated with Increased Maternal Levels and Trajectories of Cardiovascular Disease Biomarkers During and After Pregnancy.
    Parikh NI; Laria B; Nah G; Singhal M; Vittinghoff E; Vieten C; Stotland N; Coleman-Phox K; Adler N; Albert MA; Epel E
    J Womens Health (Larchmt); 2020 Oct; 29(10):1283-1291. PubMed ID: 31934809
    [No Abstract]   [Full Text] [Related]  

  • 14. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of preeclampsia and eclampsia on maternal metabolic and biochemical outcomes in later life: a systematic review and meta-analysis.
    Alonso-Ventura V; Li Y; Pasupuleti V; Roman YM; Hernandez AV; Pérez-López FR
    Metabolism; 2020 Jan; 102():154012. PubMed ID: 31734276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies?
    Hermes W; Koopmans CM; van Pampus MG; Franx A; Bloemenkamp KW; van der Post J; Porath M; Tamsma JT; Mol BW; de Groot CJ
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):30-4. PubMed ID: 24011382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early postpartum metabolic syndrome in women with or without gestational diabetes: Results from Life after Gestational Diabetes Ahvaz cohort study.
    Nouhjah S; Shahbazian H; Shahbazian N; Jahanfar S; Jahanshahi A; Cheraghian B; Mohammadi ZD; Ghodrati N; Houshmandi S
    Diabetes Metab Syndr; 2018 May; 12(3):317-323. PubMed ID: 29289537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia.
    Uckan K; Sahin HG
    J Obstet Gynaecol Res; 2018 Mar; 44(3):440-447. PubMed ID: 29345041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provoking factors for postpartum chronic hypertension in women with preceding gestational hypertension/preeclampsia: A longitudinal cohort study of 22,798 pregnancies.
    Chen KH; Chen LR
    Int J Med Sci; 2020; 17(4):543-548. PubMed ID: 32174785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.